Andrea Kuhnl

King's College Hospital

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Tim Illidge

The University of Manchester

UNITED KINGDOM

View details

Sally Barrington

King’s College London

UNITED KINGDOM

View details

Claire Roddie

University Hospital

UNITED KINGDOM

View details

Andrew Davies

University of Southampton

UNITED KINGDOM

View details

Graham McIlroy

NIHR Academic Clinical Lecturer in Haematology

University of Birmingham

UNITED KINGDOM

View details

Reuben Benjamin

Consultant Haematologist and Clinical Senior Lecturer

King's College Hospital

UNITED KINGDOM

View details

Piers Patten

King’s College London

UNITED KINGDOM

View details

Adrian Bloor

MAHSC Honorary Clinical Professor

University of Manchester

UNITED KINGDOM

View details

Robin Sanderson

Honorary Senior Lecturer

King’s College London

UNITED KINGDOM

View details

Christopher Paul Fox

Clinical Professor of Haematology

University of Nottingham

UNITED KINGDOM

View details

Angela Hwang

University College London Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Sanne Lugthart

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea Kuhnl

Research Interests

Explore related searches

Contact this professor

Articles (17)

MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapy

CD19 chimeric antigen receptor T‐cell efficacy and toxicity in adults with Richter's transformation and response to bridging therapy

Management of relapsed or refractory large B‐cell lymphoma: A British Society for Haematology Guideline

The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline

Outcome and feasibility of radiotherapy bridging in large B‐cell lymphoma patients receiving CD19 CAR T in the UK

High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma

Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real‐world intention‐to‐treat analysis

Chimeric Antigen Receptor T-Cell Therapy and Imaging Applications for Large B-Cell Lymphoma

CAR T in patients with large B‐cell lymphoma not fit for autologous transplant

A national service for delivering CD19 CAR-Tin large B-cell lymphoma – The UK real-world experience

Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis.

Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma.

Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL

Human Herpesvirus 6 Encephalitis Following <i>Axicabtagene Ciloleucel</i> Treatment for Refractory Diffuse Large B Cell Lymphoma.

Chimeric antigen receptor T‐cell toxicities – using steroids to spare steroids?

Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy

Factors Affecting Outcome of Bridging Radiotherapy (RT) Before CAR-T for High Grade Lymphoma

Collaborators (12)

Tim Illidge

Sally Barrington

Claire Roddie

Andrew Davies

Graham McIlroy

Reuben Benjamin

Piers Patten

Adrian Bloor

Robin Sanderson

Christopher Paul Fox

Angela Hwang

Sanne Lugthart

Make your next move.